Biotech Values

[dav1234]

The FDA approves Bristol-Myers' (BMY) anti-clotting drug Eliquis. The drug, which reduces the risk of stroke and dangerous blood clots in patients with atrial fibrillation, is manufactured by BMY and co-marketed by Pfizer (PFE). Shares +1.7% AH

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333634.htm